A detailed history of Opaleye Management Inc. transactions in Biodesix Inc stock. As of the latest transaction made, Opaleye Management Inc. holds 3,815,000 shares of BDSX stock, worth $4.88 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares
3,815,000
Previous 4,020,000 5.1%
Holding current value
$4.88 Million
Previous $6.15 Million 10.41%
% of portfolio
1.24%
Previous 1.58%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.53 - $1.96 $313,650 - $401,800
-205,000 Reduced 5.1%
3,815,000 $6.79 Million
Q2 2024

Aug 14, 2024

BUY
$1.21 - $1.71 $4.22 Million - $5.96 Million
3,485,343 Added 651.88%
4,020,000 $6.15 Million
Q1 2024

May 15, 2024

BUY
$1.35 - $2.12 $51,511 - $80,892
38,157 Added 7.69%
534,657 $764,000
Q4 2023

Feb 14, 2024

BUY
$1.2 - $2.13 $49,112 - $87,174
40,927 Added 8.98%
496,500 $913,000
Q3 2023

Nov 14, 2023

BUY
$1.04 - $1.74 $473,795 - $792,697
455,573 New
455,573 $751,000

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $51.2M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.